Majority owner: Lundbeck's new share structure could double acquisition power
A new proposed split share structure could give Lundbeck’s majority shareholder, the Lundbeck Foundation, the option to maintain influence while enabling billion-dollar investment hunts. Consequently, the pharmaceutical firm’s acquisition capacity could be doubled, the foundation’s CEO says.
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen
Should Lundbeck succeed in adopting a new share structure dividing shares into two categories, the pharmaceutical company could gain the option to go on billion-dollar external financing hunts without the Lundbeck Foundation, majority shareholder, having to relinquish any power.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck's Northera took massive dive in 2021
For subscribers
